Atomet Extended Release Tablet 10/1000 mg

Adult dose

For adults only, administer once daily with the evening meal.

This medication can rarely cause a serious condition called lactic acidosis, which has been reported to result in death. Care should be taken when using this medication together with insulin or sulfonylurea medications, as it may cause severe hypoglycemia. If muscle-related abnormal symptoms occur or if there is a significant increase in blood creatine kinase levels, treatment should be stopped immediately, and the medication should be temporarily discontinued in cases of severe muscle disease risk. Patients with severely impaired kidney function, dehydration, acute states such as severe infection or acute myocardial infarction should not use this medication. Patients with acute and unstable heart failure or those who plan to use iodine-based contrast agents should also not be administered this medication, and drug administration should be stopped before and after contrast agent tests to check kidney function. This medication should not be administered to patients with hypersensitivity to its components or those with specific conditions such as type 1 diabetes, diabetic ketoacidosis, severe infections, or pre- and postoperative states. Patients with malnutrition, liver dysfunction, pregnant or breastfeeding women, and children under 10 years old are also prohibited from using this medication. Patients with irregular meals, vigorous exercise, those taking certain medications, or with a history of alcohol abuse or liver disease should use this medication with caution. While taking this medication, gastrointestinal disturbances, myalgia, liver function abnormalities, and hypoglycemia may occur; if symptoms arise, immediate consultation with a physician is necessary. In particular, if myalgia or muscle weakness worsens, inform a physician and confirm possible muscle damage through blood tests. The risk of lactic acidosis may increase when taken with alcohol; therefore, it is advisable to avoid alcohol while on this medication. Women who are pregnant or may become pregnant should not take this medication and should use appropriate contraception. Breastfeeding women are also recommended not to take this medication, and should consult a specialist if necessary. Elderly patients may have a risk of decreased kidney function, so dose adjustment and regular kidney function tests are necessary. In case of overdose, there is no specific antidote; treatment should be symptomatic, and prompt medical intervention is required.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, peeling skin, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, jaundice, extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urination

Mild side effects

• Nausea
• diarrhea
• dyspepsia
• epigastric pain
• constipation
• gastritis
• gastrointestinal disturbances
• vomiting
• irritable bowel syndrome
• hypoglycemia

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature.

Appearance

Light yellow, oval-shaped, double convex, film-coated tablet

Package unit

30 tablets/bottle, 7 tablets/bottle